Deracemization By Simultaneous Bio-oxidative Kinetic Resolution and Stereoinversion
Deracemization, that is, the transformation of a racemate into a single product enantiomer with theoretically 100 % conversion and 100 % ee, is an appealing but also challenging option for asymmetric synthesis. Herein a novel chemo‐enzymatic deracemization concept by a cascade is described: the path...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 53; no. 14; pp. 3731 - 3734 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.04.2014
WILEY‐VCH Verlag Wiley Wiley Subscription Services, Inc |
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Deracemization, that is, the transformation of a racemate into a single product enantiomer with theoretically 100 % conversion and 100 % ee, is an appealing but also challenging option for asymmetric synthesis. Herein a novel chemo‐enzymatic deracemization concept by a cascade is described: the pathway involves two enantioselective oxidation steps and one non‐stereoselective reduction step, enabling stereoinversion and a simultaneous kinetic resolution. The concept was exemplified for the transformation of rac‐benzylisoquinolines to optically pure (S)‐berbines. The racemic substrates were transformed to optically pure products (ee>97 %) with up to 98 % conversion and up to 88 % yield of isolated product.
From two make one: Chemo‐enzymatic stereoinversion and enzymatic kinetic resolution have been combined in a simultaneous cascade process to transform racemic substrates (A, ent‐A) into optically pure product P. The concept was exemplified for benzylisoquinolines rac‐1 yielding optically pure berbines (S)‐2. The reaction system comprised a monoamine oxidase (MAO‐N), morpholine‐borane, and the berberine bridge enzyme (BBE). |
---|---|
Bibliography: | Funded Access Austrian Science Fund - No. P20903-N17; No. P22115-N17 European Union - No. 289646 Marie Curie ITN - No. FP7-ITN-238531 This study was financed by the Austrian Science Fund (FWF Project P20903-N17 and P22115-N17). E.-M.F. received funding from the European Union's seventh framework program FP7/2007-2013 under grant agreement no. 289646 (KyroBio). B.G. and D.G. were supported by a Marie Curie ITN (Biotrains FP7-ITN-238531), and we also acknowledge a Royal Society Wolfson Merit Award to N.J.T. ark:/67375/WNG-KSQZDPZ4-X Royal Society istex:325BBCEE70EC7F9CA3F828CF0AAD87858FAF5AB3 ArticleID:ANIE201400027 This study was financed by the Austrian Science Fund (FWF Project P20903‐N17 and P22115‐N17). E.‐M.F. received funding from the European Union’s seventh framework program FP7/2007–2013 under grant agreement no. 289646 (KyroBio). B.G. and D.G. were supported by a Marie Curie ITN (Biotrains FP7‐ITN‐238531), and we also acknowledge a Royal Society Wolfson Merit Award to N.J.T. researchfish ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This study was financed by the Austrian Science Fund (FWF Project P20903-N17 and P22115-N17). E.-M.F. received funding from the European Union’s seventh framework program FP7/2007–2013 under grant agreement no. 289646 (KyroBio). B.G. and D.G. were supported by a Marie Curie ITN (Biotrains FP7-ITN-238531), and we also acknowledge a Royal Society Wolfson Merit Award to N.J.T. |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201400027 |